SCHEMBL18530503

SCHEMBL18530503

CN(C(=O)O)c1ccc(-c2ccc(-c3ccc(C(=O)N4CCC(F)(F)CC4)cc3)cc2-c2ccc(F)cc2)o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAK4 O96013 2/20 0.41
▸ NAMPT P43490 1/20 0.41
▸ PAK1 Q13153 1/20 0.41
▸ FASN P49327 5/20 0.40
▸ SLC6A7 Q99884 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HDAC3 O15379 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HSD11B1 P28845 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ BCR P11274 1/20 0.37
▸ CNR1 P21554 1/20 0.36
▸ TDO2 P48775 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18530622 0.92 FASN (0.38) PAK4NAMPTPAK1FASNMEN1
SCHEMBL18530486 0.87 SLC6A7 (0.42) FASNSLC6A7MEN1KMT2AALDH1A1
SCHEMBL19066884 0.83 PAK4 (0.52) PAK4NAMPTPAK1FASNSLC6A7
SCHEMBL18530519 0.81 PAK4 (0.47) PAK4NAMPTPAK1FASNSLC6A7
SCHEMBL19066867 0.80 PAK4 (0.49) PAK4NAMPTPAK1FASNSLC6A7
SCHEMBL19066871 0.78 PAK4 (0.45) PAK4NAMPTPAK1FASNSLC6A7
SCHEMBL18530652 0.77 PAK4 (0.38) PAK4FASNCNR1SMN1; SMN2
SCHEMBL18530546 0.76 HPGD (0.35) KMT2ACNR1MAPTSMN1; SMN2
SCHEMBL18530607 0.76 CCNC (0.37) DPP4DPP7
SCHEMBL18542169 0.76 PAK4 (0.46) PAK4NAMPTPAK1FASNHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3337796-A1 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS Karyopharm Therapeutics, Inc. (US) 2018-06-27 — — EP disclosed
WO-2017117447-A1 MULTICYCLIC COMPOUNDS AND USES THEREOF Karyopharm Therapeutics Inc. (US) 2017-07-06 — — WO disclosed
WO-2017031213-A1 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS Karyopharm Therapeutics Inc. (US) 2017-02-23 — — WO disclosed
Send feedback